SFM
NVCT icon

Sphera Funds Management’s Nuvectis Pharma NVCT Stock Holding History

Sphera Funds Management’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04M Buy
+382,945
New +$4.29M 0.92% 38

Other funds holding NVCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sphera Funds Management's NVCT Position: Q2 2026 in Review

Sphera Funds Management opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 382,945 shares worth $7.04M. The stake represents 0.92% of the portfolio and ranks #38 among its holdings.

75 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Sphera Funds Management held 382,945 shares of Nuvectis Pharma worth $7.04M as of Q2 2026.
  • Nuvectis Pharma was a new Sphera Funds Management position in Q2 2026.
  • Nuvectis Pharma made up 0.92% of Sphera Funds Management's portfolio in Q2 2026, its #38 holding.
  • 75 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.